1. Home
  2. GANX vs SLMT Comparison

GANX vs SLMT Comparison

Compare GANX & SLMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gain Therapeutics Inc.

GANX

Gain Therapeutics Inc.

HOLD

Current Price

$1.88

Market Cap

76.4M

Sector

Health Care

ML Signal

HOLD

Logo Brera Holdings PLC Class B Ordinary Shares

SLMT

Brera Holdings PLC Class B Ordinary Shares

HOLD

Current Price

$5.56

Market Cap

68.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GANX
SLMT
Founded
2017
2000
Country
United States
Ireland
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
68.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
GANX
SLMT
Price
$1.88
$5.56
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.50
N/A
AVG Volume (30 Days)
655.7K
125.1K
Earning Date
05-13-2026
06-13-2026
Dividend Yield
N/A
N/A
EPS Growth
31.46
N/A
EPS
N/A
N/A
Revenue
$55,180.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.56
52 Week High
$4.34
$24.05

Technical Indicators

Market Signals
Indicator
GANX
SLMT
Relative Strength Index (RSI) 56.36 58.52
Support Level $1.73 $0.79
Resistance Level $2.12 $6.86
Average True Range (ATR) 0.11 0.83
MACD 0.02 -0.13
Stochastic Oscillator 70.21 47.94

Price Performance

Historical Comparison
GANX
SLMT

About GANX Gain Therapeutics Inc.

Gain Therapeutics Inc is a clinical-stage biotechnology company developing novel small-molecule therapeutics to treat diseases across several therapeutic areas, including central nervous system (CNS) disorders, lysosomal storage disorders (LSDs), metabolic disorders, and other diseases that can be targeted through protein degradation, such as oncology. The Company's clinical stage product candidate, GT-02287, is being developed for the treatment of Parkinson's disease with and without GBA1 mutations. The Company generated an extensive preclinical data package providing evidence of the mechanism of action.

About SLMT Brera Holdings PLC Class B Ordinary Shares

Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: